References
- Mirra J. Bone tumors: clinical, radiologic and pathologic correlations. Philadelphia-London: Lea & Febiger, 1989: 766-796.
- Campanacci M. Bone and soft tissue tumors. Wien, New York: Springer-Verlag, 1990: 171-181.
- Feldnam F, Norman D. Intra- and extraosseous malig-nant histiocytoma (malignant fibrous xanthoma). Radiology 1972; 104: 497–508.
- Capanna R, Bertoni F, Bacchini P et al. Malignant fibrous histiocytoma of bone: the experience at the Rizzoli Institute. Report of 90 cases. Cancer 1984; 54: 177–187.
- Dahlin DC, Unni KK, Matsuno T. Malignant (fibrous) histiocytoma of bone: fact or fancy? Cancer 1977; 39: 1508-1516.
- Huvos AG, Heilweil M, Brestky SS. The pathology of malignant fibrous histiocytoma of bone: a study of 130 patients. Am J Surg Pathol 1985; 9: 853–871.
- McCarthy EF, Matsuno T, Dofman HD. Malignant fibrous histiocytoma of bone: a study of 35 cases. Human Pathol 1979; 10: 57–70.
- Spanier SS, Enneking WF, Enriquez P. Primary malig-nant fibrous histiocytoma of bone. Cancer 1975; 36: 2084–2098.
- Dunham WK, Wilbom VC/H. Malignant fibrous histiocy-toma of bone: report of two cases and review of the literature. J Bone Joint Surg 1979; 61: 939–942.
- Chawla SP, Benjamin RS, Fadi W, et al. Neoadjuvant chemotherapy of primary malignant fibrous histiocytoma of bone. In: Salomon S, Adjuvant chemotherapy of cancer. New York: Grune & Stratton, 1984: 621-629.
- Urban C, Rosen G, Huvos AG et al. Chemotherapy of malignant fibrous histiocytoma of bone: a report of five cases. Cancer 1983; 51: 795–802.
- Den Heeten GJ, Koops HS, Kamps W et al. Treatment of malignant fibrous histiocythoma of bone. A plan for prima-ry chemotherapy. Cancer 1985; 56: 37–40.
- Bacci G, AveIla M, Picci P et al. The effectiveness of chemotherapy in localized malignant histiocytoma of bone: the Rizzoli Institute experience with 66 patients treated with surgery alone or surgery plus adjuvant or neoadjuvant chemo-therapy. Chemioterapia 1988; 7: 406–413.
- Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthoped 1980; 153: 106–120.
- Picci P, Bacci G, Campanacci M et al. Histologic evalu-ation of tumor necrosis in osteosarcoma induced by chemo-therapy. Cancer 1985; 56: 1515–1521.
- Bacci G, Springfield D, Capanna R et al. Adjuvant chemotherapy for malignant fibrous histiocytoma in the femur and tibia. J Bone Joint Surg, 1985; 67- 620-625.
- Campanacci M, Bacci G, Bertoni F, Picci P, Minutillo A, Franceschi C. The treatment of osteosarcoma of the extremity: twenty year's experience at the Istituto Ortopedico Rizzoli. Cancer 1981; 48: 1456–1461.
- Bacci G, Picci P, Ferrari S et al. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremity. Cancer 1993; 72: 3224–3238.
- Winkkler K, Beron G, Delling G, et al. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized coop-erative trial (COSS-82) with salvage chemotherapy based on histologic tumor response. J Chin Oncol 1988; 6: 239–336.
- Rosen G. Preoperative (neoadjuvant) chemotherapy for osteogenic sarcoma: a ten year experience. Orthopaedics 1985; 8: 659–664.
- Saeter G, Alvegard A, Elomaa I et al. Treatment of osteosarcoma of the extremity with the T-10 protocol (with emphasis on the effects of preoperative chemotherapy with single agent high dose methotrexate): a Scandinavian Sarcoma Group Study. J Chin Oncol 1991; 9: 1766–1775.